Joint study on the DNA mismatch repair system : Functional analysis of the DNA mismatch repair genes using Saccharomyces cerevisiae.
Joint study on the DNA mismatch repair system : Functional analysis of the DNA mismatch repair genes using Saccharomyces cerevisiae.
批准号:
08044234
负责人:
ISHIOKA Chikashi
金额:
$3.84万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1. We have developed the expression system of human mismatch repair genes, hMLH1 and hMSH2 in Saccharomyces cerevisiae. We have also constructed a series of yeast strains with mismatch repair defect. When hMLH1 cDNA was expressed in mismatch repair-deficient mlhl strain, the transformants demonstrated to suppress partially the mutator phenotype. When hMLH1 cDNA was also expressed in mismatch repair-proficient strain, the transformants demonstrated to be mutator phenotype, due to dominat mutator effect of the hMLH1. Using the later phenotype, we have analyzed 27 hMLH1 sequenceari ants including 21 amno acid substitutions, 2 nonsense mutations, 2 in-frame deletions and 2 carboxy-terminal frameshift mutations. Among these, 25 variants showed no effect on the dominant mutator effect, indicating that these hMLH1 are pathogenic mutations. Two variants reported as missense mutations retained the ability to indicate dominant mutator effect, suggesting that these variants may be polymorphisms. Remaining two variants reported as polymorphisms retained the dominant mutator effect, suggesting that this type of assay has potentially detect unknown loss-of-function mutations. The assay developed in this study could be helpful for better understanding of genetics of HNPCC.2. According to the muation data base of the International Collaborating Group of HNPCC (ICG-HNPCC) and our international survey of unpublished muatations through this joint study, nearly 200 different hMSH2 and hMLH1 mutations have been documented. Among these, approxymately 10% of hMSH2 mutations and 30% of hMLH1 mutations were missense mutations, indicating that there is a significant fraction of HNPCC mutations which need to clarify their functional significance on pathogenicity in order to discriminate from non-pathogenic polymorphisms.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Li-Qun,Jia et al.: "Screening the p53 status of human cell lines using a yeast functional assay." Mol. Carcinogenesis. (in press). (1997)
Li-Qun, Jia 等人:“使用酵母功能测定筛选人类细胞系的 p53 状态。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hartwell, L.H., Szankasi, P., Roberts, C.J., Murray, A.W., and Friend, S.H.: "Integrating genetic approaches into the discovery of anticancer drugs." Science. 278. 1064-8 (1997)
Hartwell, L.H.、Szankasi, P.、Roberts, C.J.、Murray, A.W. 和 Friend, S.H.:“将遗传方法整合到抗癌药物的发现中。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishioka, C., Suzuki, T., FitzGerald, M., Krainer, M., Shimodaira, H., Shimada, A., Nomizu, T., Isselbacher, K.J., Haber, D., and Kanamaru, R.: "Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in y
Ishioka, C.、Suzuki, T.、FitzGerald, M.、Krainer, M.、Shimodaira, H.、Shimada, A.、Nomizu, T.、Isselbacher, K.J.、Haber, D. 和 Kanamaru, R.:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Lehland Hartwell: "Integrating genetic approaches into the discovery of anticancer drugs." Science. 278. 1064-1068 (1997)
Lehland Hartwell:“将基因方法融入抗癌药物的发现中。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hackman, P., Tannergard, P., Osei-Mensa, S., Chen, J., Kane, M.F., Kolodner, R., Lambert, B., Hellgren, D., and Lindblom, A: "A human compound heterozygote for two MLH1 missense mutations." Nature Genet.17. 135-6 (1997)
Hackman, P.、Tannergard, P.、Osei-Mensa, S.、Chen, J.、Kane, M.F.、Kolodner, R.、Lambert, B.、Hellgren, D. 和 Lindblom, A:“一种人类化合物
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Research on pathogenesis of DNA-highly methylated type colorectal cancer and the development of diagnosis and treatment methods
-
批准号:19H03508
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2019
-
负责人:ISHIOKA Chikashi
-
依托单位:
A search and optimization of the novel cancer molecules target drugs with PI3K/HDAC dual inhibition
-
批准号:24300339
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2012
-
负责人:ISHIOKA Chikashi
-
依托单位:
Search of mutant p53-specific target of cancer cells
-
批准号:24650642
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.5万
-
财政年份:2012
-
负责人:ISHIOKA Chikashi
-
依托单位:
Screening molecular markers for prediction of recurrence and prognosis of colorectal cancer.
-
批准号:20390163
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2008
-
负责人:ISHIOKA Chikashi
-
依托单位:
Development of functional assays for tumor-related genes
-
批准号:17015002
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$82.88万
-
财政年份:2005
-
负责人:ISHIOKA Chikashi
-
依托单位:
Development of p53-associated molecular devices for diagnosis and treatment of gastrointestinal cancer
-
批准号:14370173
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.96万
-
财政年份:2002
-
负责人:ISHIOKA Chikashi
-
依托单位:
Functional mapping of missens mutations in hMLH1 gene
-
批准号:11470503
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.93万
-
财政年份:1999
-
负责人:ISHIOKA Chikashi
-
依托单位:
Development of yeast-based screening method for cancer-related genes and its clinical applications
-
批准号:09557206
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.4万
-
财政年份:1997
-
负责人:ISHIOKA Chikashi
-
依托单位:
Development of a novel method for genetic diagnosis of hereditary colon cancer syndromes using yeast.
-
批准号:08670549
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:ISHIOKA Chikashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CDYL通过调控hMLH1启动子区组蛋白H3K27三甲基化促进小细胞肺癌耐药的研究
-
批准号:81672267
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2016
-
负责人:张健
-
依托单位:
错配修复基因hMLH1在雌激素诱导结肠细胞凋亡中的作用
-
批准号:81201958
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:金鹏
-
依托单位:
EZH2调控DNA错配修复基因hMLH1在结肠癌干细胞自我更新的作用及机制研究
-
批准号:81101629
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈建芳
-
依托单位:
雌激素调节错配修复基因hMLH1表达的机制研究
-
批准号:81072041
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:盛剑秋
-
依托单位:
人类错配修复基因hMLH1与hMSH2错义突变的功能研究
-
批准号:81060192
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2010
-
负责人:郭嘉义
-
依托单位:
EZH2介导H3-K27甲基化调控卵巢癌耐药相关基因hMLH1启动子甲基化的机制
-
批准号:30901585
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:于利利
-
依托单位:
散发型胰岛素瘤错配修复基因hMLH1和hMSH2异常的研究
-
批准号:30570694
-
项目类别:面上项目
-
资助金额:25.0万元
-
批准年份:2005
-
负责人:陈原稼
-
依托单位:
国人HNPCC hMSH2和hMLH1基因胚系突变检测及临床意义
-
批准号:39970817
-
项目类别:面上项目
-
资助金额:13.0万元
-
批准年份:1999
-
负责人:王振军
-
依托单位:
DNA修复蛋白HMSH2和HMLH1基因与大肠癌的关系的研究
-
批准号:39560036
-
项目类别:地区科学基金项目
-
资助金额:6.0万元
-
批准年份:1995
-
负责人:蔡望伟
-
依托单位: